Particulars |
|
|
|
Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
105.30 |
Sales(₹ Cr.) |
3,407.25 |
NP (₹ Cr.) |
686.46 |
NP Var (%) |
17.00 |
Div% |
320.00 |
CPS(₹) |
44.60 |
EPS (₹) |
40.50 |
Traded Value(₹ Lakhs) |
1,320.31 |
52 Week High |
2,650.00 |
52 Week Low |
1,265.00 |
Price BSE |
2,292.00 |
Price NSE |
2,287.00 |
Market Capital (₹ Cr.) |
38,820.24 |
P/C Ratio |
51.40 |
P/E Ratio |
56.60 |
Price Vs.BV |
21.77 |
|
Latest Quarter |
Year End |
202403 |
Sales (₹ Cr.) |
910.87 |
NP(₹ Cr.) |
191.36 |
NP Var % |
54.00 |
Trailing Twelve Months |
Year End |
202403 |
Sales |
3,234.97 |
OPM |
27.84 |
NP |
412.71 |
NP Var (%) |
17.00 |
EPS |
40.52 |
PE |
56.55 |
|
|